X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (483) 483
Patent (66) 66
Publication (66) 66
Book Review (57) 57
Conference Proceeding (37) 37
Book Chapter (7) 7
Government Document (3) 3
Magazine Article (2) 2
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (291) 291
humans (281) 281
oncology (263) 263
female (247) 247
breast cancer (203) 203
breast neoplasms - drug therapy (145) 145
breast neoplasms - genetics (138) 138
middle aged (132) 132
breast neoplasms - pathology (128) 128
cancer (114) 114
chemotherapy (114) 114
adult (100) 100
prognosis (99) 99
aged (98) 98
gene expression profiling (69) 69
research (68) 68
gene expression (66) 66
antineoplastic combined chemotherapy protocols - therapeutic use (64) 64
breast neoplasms - metabolism (58) 58
treatment outcome (57) 57
neoadjuvant therapy (56) 56
preoperative chemotherapy (51) 51
survival (51) 51
gene expression regulation, neoplastic (49) 49
tumors (49) 49
chemistry (47) 47
care and treatment (46) 46
chemotherapy, adjuvant (46) 46
neoplasm staging (46) 46
metallurgy (45) 45
biochemistry (44) 44
genetic aspects (44) 44
physics (44) 44
antineoplastic agents - therapeutic use (42) 42
abridged index medicus (40) 40
beer (40) 40
compositions or test papers therefor (40) 40
condition-responsive control in microbiological orenzymological processes (40) 40
enzymology (40) 40
measuring or testing processes involving enzymes, nucleicacids or microorganisms (40) 40
microbiology (40) 40
mutation or genetic engineering (40) 40
processes of preparing such compositions (40) 40
spirits (40) 40
therapy (40) 40
vinegar (40) 40
wine (40) 40
medicine & public health (39) 39
neoadjuvant chemotherapy (38) 38
article (37) 37
breast neoplasms - diagnosis (37) 37
predictive value of tests (37) 37
receptors, estrogen - metabolism (37) 37
doxorubicin (36) 36
trastuzumab (35) 35
receptor, erbb-2 - metabolism (34) 34
testing (34) 34
investigating or analysing materials by determining theirchemical or physical properties (33) 33
measuring (33) 33
oligonucleotide array sequence analysis (33) 33
aged, 80 and over (32) 32
breast neoplasms - mortality (32) 32
women (32) 32
cyclophosphamide (31) 31
breast neoplasms - therapy (30) 30
gene-expression profiles (30) 30
genes (30) 30
paclitaxel (30) 30
biomarkers (29) 29
breast neoplasms - surgery (29) 29
carcinoma (28) 28
paclitaxel - administration & dosage (28) 28
analysis (27) 27
estrogen (27) 27
expression (27) 27
adjuvant treatment (26) 26
diagnosis (26) 26
disease-free survival (26) 26
health aspects (26) 26
metastasis (26) 26
pathological complete response (26) 26
sensitivity (26) 26
mutation (25) 25
tamoxifen (25) 25
genomics (24) 24
immunohistochemistry (24) 24
biomarkers, tumor - genetics (23) 23
cells (23) 23
clinical trials (23) 23
drug therapy (22) 22
gene-expression (22) 22
risk factors (22) 22
survival analysis (22) 22
biomarkers, tumor - analysis (21) 21
docetaxel (21) 21
research article (21) 21
subtypes (21) 21
reproducibility of results (20) 20
usage (20) 20
adjuvant chemotherapy (19) 19
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Clinical Oncology, ISSN 1759-4774, 12/2015, Volume 12, Issue 12, pp. 690 - 691
Journal Article
Cancer, ISSN 0008-543X, 04/2011, Volume 117, Issue 8, pp. 1575 - 1582
Breast cancer is a heterogeneous disease of different subtypes on the molecular, histopathological, and clinical level. Genomic profiling techniques have led... 
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9816, pp. 633 - 640
Summary Background The anti-HER2 monoclonal antibody trastuzumab and the tyrosine kinase inhibitor lapatinib have complementary mechanisms of action and... 
Internal Medicine | ADJUVANT CHEMOTHERAPY | APOPTOSIS | CELLS | WOMEN | MEDICINE, GENERAL & INTERNAL | GW572016 | ERBB2 | INHIBITOR | PLUS | Breast Neoplasms - surgery | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Diarrhea - chemically induced | Breast Neoplasms - chemistry | Antibodies, Monoclonal, Humanized - administration & dosage | Liver - drug effects | Adult | Female | Quinazolines - administration & dosage | Receptor, ErbB-2 - antagonists & inhibitors | Chemotherapy, Adjuvant | Biomarkers, Tumor - antagonists & inhibitors | Paclitaxel - administration & dosage | Antibodies, Monoclonal, Humanized - adverse effects | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Liver - metabolism | Paclitaxel - adverse effects | Treatment Outcome | Breast Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Neoadjuvant Therapy - methods | Quinazolines - adverse effects | Aged | Infusions, Intravenous | Receptor, ErbB-2 - analysis | Trastuzumab | Drug therapy | Breast cancer | Genetic aspects | Medical research | Ligands | Cytotoxicity | Mammography | Kinases | Cancer therapies | Index Medicus | Abridged Index Medicus | pathology | Liver | methods | Antibodies | Oral | Quinazolines | Breast Neoplasms | Tumor Markers | administration & dosage | Surgery | Paclitaxel | Neoadjuvant Therapy | Adjuvant | Monoclonal | chemistry | Administration | drug therapy | chemically induced | Intravenous | Infusions | Humanized | Antineoplastic Combined Chemotherapy Protocols | Diarrhea | drug effects | Biological | analysis | Kirurgi | antagonists & inhibitors | Chemotherapy | Receptor | adverse effects | metabolism | Cancer and Oncology | therapeutic use | Cancer och onkologi | erbB-2
Journal Article
Nature Biotechnology, ISSN 1087-0156, 11/2013, Volume 31, Issue 11, pp. 1023 - 1031
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2008, Volume 26, Issue 8, pp. 1275 - 1281
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2012, Volume 30, Issue 23, pp. 2931 - 2931
Journal Article
Nature medicine, ISSN 1078-8956, 11/2014, Volume 20, Issue 11, pp. 1301 - 1309
Some of the anti-neoplastic effects of anthracyclines in mice originate from the induction of innate and T cell-mediated anticancer immune responses. Here we... 
MEDICINE, RESEARCH & EXPERIMENTAL | DOUBLE-STRANDED-RNA | DENDRITIC CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | INNATE | RIG-I | TUMORS | CELL BIOLOGY | TOLL-LIKE RECEPTOR-3 | BREAST-CANCER | ANTICANCER CHEMOTHERAPY | GENE | IMMUNE-RESPONSES | Doxorubicin - therapeutic use | Breast Neoplasms - immunology | Humans | RNA, Messenger - metabolism | Adaptor Proteins, Vesicular Transport - metabolism | Interferon Type I - biosynthesis | Receptors, Pattern Recognition - metabolism | Neoplasm Metastasis | Anthracyclines - pharmacology | Interferon Type I - metabolism | Female | Neoadjuvant Therapy | Gene Expression Regulation, Neoplastic - drug effects | RNA - metabolism | Receptor, Interferon alpha-beta - metabolism | Mice, Inbred C57BL | RNA, Messenger - genetics | Treatment Outcome | Toll-Like Receptor 3 - metabolism | Breast Neoplasms - drug therapy | Animals | Breast Neoplasms - genetics | Signal Transduction - drug effects | Breast Neoplasms - pathology | Immunocompetence - drug effects | Anthracyclines - therapeutic use | Chemokine CXCL10 - metabolism | Myxovirus Resistance Proteins - metabolism | Doxorubicin - pharmacology | Anthracyclines | Care and treatment | Analysis | Physiological aspects | Interferon | Research | Cancer | Signal transduction | Chemotherapy | Breast cancer | Chemokines | Index Medicus | Life Sciences | Immunology | Immunotherapy
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 5/2012, Volume 19, Issue 5, pp. 1508 - 1516
Journal Article